Breast Cancer and MiR-SNPs: The Importance of MiR Germ-Line Genetics

Overview

Journal Noncoding RNA

Date 2019 Mar 23

PMID 30897768

Citations 9

Authors

Poonam Malhotra

Graham H Read

Joanne B Weidhaas

Affiliations

Soon will be listed here.

Abstract

Recent studies in cancer diagnostics have identified microRNAs (miRNAs) as promising cancer biomarkers. Single nucleotide polymorphisms (SNPs) in miRNA binding sites, seed regions, and coding sequences can help predict breast cancer risk, aggressiveness, response to stimuli, and prognosis. This review also documents significant known miR-SNPs in miRNA biogenesis genes and their effects on gene regulation in breast cancer, taking into account the genetic background and ethnicity of the sampled populations. When applicable, miR-SNPs are evaluated in the context of other patient factors, including mutations, hormonal status, and demographics. Given the power of miR-SNPs to predict patient cancer risk, prognosis, and outcomes, further study of miR-SNPs is warranted to improve efforts towards personalized medicine.

Citing Articles

The Association of pri-miR34 b/c Gene Polymorphism and Clinicopathologic Data in Breast Cancer Patients.

Kongton T, Sanguansin S, Saelee P, Thongmee A, Pongstaporn W Asian Pac J Cancer Prev. 2024; 25(7):2415-2420.

PMID: 39068575 PMC: 11480604. DOI: 10.31557/APJCP.2024.25.7.2415.

IsomiR-eQTL: A Cancer-Specific Expression Quantitative Trait Loci Database of miRNAs and Their Isoforms.

Moradi A, Whatmore P, Farashi S, Barrero R, Batra J Int J Mol Sci. 2022; 23(20).

PMID: 36293349 PMC: 9604134. DOI: 10.3390/ijms232012493.

Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.

Kishan A, Marco N, Schulz-Jaavall M, Steinberg M, Tran P, Juarez J Radiother Oncol. 2022; 167:226-232.

PMID: 34990726 PMC: 8979583. DOI: 10.1016/j.radonc.2021.12.040.

SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes.

Chhichholiya Y, Suryan A, Suman P, Munshi A, Singh S Front Genet. 2021; 12:793523.

PMID: 34925466 PMC: 8673831. DOI: 10.3389/fgene.2021.793523.

The miR526b-5p-Related Single Nucleotide Polymorphisms, rs72618599, Located in 3'-UTR of TCF3 Gene, is Associated with the Risk of Breast and Gastric Cancers.

Mohammadi M, Salehzadeh A, Sasani S, Tarang A Iran Biomed J. 2021; 26(1):53-63.

PMID: 34700372 PMC: 8784898. DOI: 10.52547/ibj.26.1.53.

References

Calin G, Dumitru C, Shimizu M, Bichi R, Zupo S, Noch E . Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002; 99(24):15524-9. PMC: 137750. DOI: 10.1073/pnas.242606799. View

Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B . Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100(16):9482-7. PMC: 170944. DOI: 10.1073/pnas.1633689100. View

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

Yekta S, Shih I, Bartel D . MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004; 304(5670):594-6. DOI: 10.1126/science.1097434. View

Duan R, Pak C, Jin P . Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet. 2007; 16(9):1124-31. DOI: 10.1093/hmg/ddm062. View

Chen K, Song F, Calin G, Wei Q, Hao X, Zhang W . Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis. 2008; 29(7):1306-11. DOI: 10.1093/carcin/bgn116. View

Brendle A, Lei H, Brandt A, Johansson R, Enquist K, Henriksson R . Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis. 2008; 29(7):1394-9. DOI: 10.1093/carcin/bgn126. View

Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J . Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 2008; 30(1):79-84. DOI: 10.1002/humu.20837. View

Tchatchou S, Jung A, Hemminki K, Sutter C, Wappenschmidt B, Bugert P . A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis. 2008; 30(1):59-64. DOI: 10.1093/carcin/bgn253. View

10.

Pongsavee M, Yamkamon V, Dakeng S, O-Charoenrat P, Smith D, Saunders G . The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor. Genet Test Mol Biomarkers. 2009; 13(3):307-17. DOI: 10.1089/gtmb.2008.0127. View

11.

Hoffman A, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F . microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009; 69(14):5970-7. PMC: 2716085. DOI: 10.1158/0008-5472.CAN-09-0236. View

12.

Paranjape T, Slack F, Weidhaas J . MicroRNAs: tools for cancer diagnostics. Gut. 2009; 58(11):1546-54. PMC: 2802653. DOI: 10.1136/gut.2009.179531. View

13.

Iliopoulos D, Hirsch H, Struhl K . An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009; 139(4):693-706. PMC: 2783826. DOI: 10.1016/j.cell.2009.10.014. View

14.

Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, Wappenschmidt B . A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat. 2009; 121(3):693-702. DOI: 10.1007/s10549-009-0633-5. View

15.

Nicoloso M, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M . Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010; 70(7):2789-98. PMC: 2853025. DOI: 10.1158/0008-5472.CAN-09-3541. View

16.

Ryan B, Robles A, Harris C . Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010; 10(6):389-402. PMC: 2950312. DOI: 10.1038/nrc2867. View

17.

Hollestelle A, Pelletier C, Hooning M, Crepin E, Schutte M, Look M . Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families. Breast Cancer Res Treat. 2010; 128(1):79-84. PMC: 3735357. DOI: 10.1007/s10549-010-1080-z. View

18.

Pelletier C, Speed W, Paranjape T, Keane K, Blitzblau R, Hollestelle A . Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk. Cell Cycle. 2010; 10(1):90-9. PMC: 3048078. DOI: 10.4161/cc.10.1.14359. View

19.

Zheng H, Song F, Zhang L, Yang D, Ji P, Wang Y . Genetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer. Int J Oncol. 2011; 38(4):1153-61. DOI: 10.3892/ijo.2011.940. View

20.

Paranjape T, Heneghan H, Lindner R, Keane F, Hoffman A, Hollestelle A . A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Lancet Oncol. 2011; 12(4):377-86. PMC: 3488438. DOI: 10.1016/S1470-2045(11)70044-4. View